- 中国科学论文统计源期刊
- 中国科技核心期刊
- 美国化学文摘(CA)来源期刊
- 日本科学技术振兴机构数据库(JST)
临床输血与检验 ›› 2023, Vol. 25 ›› Issue (3): 425-432.DOI: 10.3969/j.issn.1671-2587.2023.03.025
• 综述 • 上一篇
杨静文, 常文娇
收稿日期:2023-03-16
发布日期:2023-07-10
通讯作者:
常文娇,副主任医师,博士,主要从事微生物学研究,（E-mail）wjchang626@126.com。
作者简介:杨静文,硕士,主要从事微生物学研究,（E-mail）17682181029@163.com。
基金资助:
Received:2023-03-16
Published:2023-07-10
摘要： 生物被膜是细菌或真菌为了适应外界环境,粘附于非生物或活性组织表面,并包被于自身产生的黏液性不均一的胞外基质中形成的一种与浮游菌生长方式不同的微生物群。随着医用植入物和假体的使用增加,免疫力低下人群增多,生物被膜相关感染的发病率逐年上升。生物被膜的形成导致细菌对抗生素广泛耐受,感染迁延难愈,严重危害人类健康。本文回顾性地对生物被膜相关感染的病原体、感染特征、诊断、治疗及预防策略等研究进展进行综述,以期为生物被膜感染防治提供参考。
中图分类号:
杨静文, 常文娇. 生物被膜感染特征及防治策略研究进展*[J]. 临床输血与检验, 2023, 25(3): 425-432.
| [1] DONLAN R M,COSTERTON J W.Biofilms:survival mechanisms of clinically relevant microorganisms[J].Clin Microbiol Rev,2002,15(2):167-193. [2] ZHAO F,YANG H X,BI D Z,et al.A systematic review and meta-analysis of antibiotic resistance patterns,and the correlation between biofilm formation with virulence factors in uropathogenic E.coli isolated from urinary tract infections[J].Microb Pathog,2020,144:104196. [3] CIOFU O,MOSER C,JENSEN P Ø,et al.Tolerance and resistance of microbial biofilms[J].Nat Rev Microbiol,2022,20(10):621-635. [4] POKHAREL K,DAWADI B R,SHRESTHA L B.Role of biofilm in bacterial infection and antimicrobial resistance[J].JNMA J Nepal Med Assoc,2022,60(253):836-840. [5] VARELA M F,STEPHEN J,LEKSHMI M,et al.Bacterial resistance to antimicrobial agents[J].Antibiotics (Basel),2021,10(5):593. [6] RIEGER U M,MESINA J,KALBERMATTEN D F,et al.Bacterial biofilms and capsular contracture in patients with breast implants[J].Br J Surg,2013,100(6):768-774. [7] JEWELL M L,FICKAS B,JEWELL H,et al.Implant surface options and biofilm mitigation strategies[J].Plast Reconstr Surg,2019,144(1S Utilizing a Spectrum of Cohesive Implants in Aesthetic and Reconstructive Breast Surgery):13S-20S. [8] STEWART P S,BJARNSHOLT T.Risk factors for chronic biofilm-related infection associated with implanted medical devices[J].Clin Microbiol Infect,2020,26(8):1034-1038. [9] ARNOLD C J,CHU V H.Cardiovascular implantable electronic device infections[J].Infect Dis Clin North Am,2018,32(4):811-825. [10] HANNAN M M,XIE R B,COWGER J,et al.Epidemiology of infection in mechanical circulatory support:a global analysis from the ISHLT Mechanically Assisted Circulatory Support Registry[J].J Heart Lung Transplant,2019,38(4):364-373. [11] WATSON E,SMITH B T,SMOAK M M,et al.Localized mandibular infection affects remote in vivo bioreactor bone generation[J].Biomaterials,2020,256:120185. [12] MÜHLSTÄDT S,ANGULO J C,MOHAMMED N,et al.Complications of the urinary incontinence system ATOMS:description of risk factors and how to prevent these pitfalls[J].World J Urol,2020,38(7):1795-1803. [13] RUPP M E,MAJORANT D.Prevention of vascular catheter-related bloodstream infections[J].Infect Dis Clin N Am,2016,30(4):853-868. [14] DEL POZO J L,AUBA C.Role of biofilms in breast implant associated infections and capsular contracture[M]//DONELLI G.Biofilm-based Healthcare-associated Infections.Cham:Springer,2015:53-67. [15] BJARNSHOLT T.The role of bacterial biofilms in chronic infections[J].APMIS,2013,121:1-58. [16] DRISCOLL J A,BRODY S L,KOLLEF M H.The epidemiology,pathogenesis and treatment of Pseudomonas aeruginosa infections[J].Drugs,2007,67(3):351-368. [17] CHOTIRMALL S H,MCELVANEY N G.Fungi in the cystic fibrosis lung:bystanders or pathogens?[J].Int J Biochem Cell Biol,2014,52:161-173. [18] KINANE D F,STATHOPOULOU P G,PAPAPANOU P N.Periodontal diseases[J].Nat Rev Dis Primers,2017,3:17038. [19] COLOMBO A P V,TANNER A C R.The role of bacterial biofilms in dental caries and periodontal and peri-implant diseases:a historical perspective[J].J Dent Res,2019,98(4):373-385. [20] MACFARLANE S.Microbial biofilm communities in the gastrointestinal tract[J].J Clin Gastroenterol,2008,42(Supplement 3):S142-S143. [21] YADAV P,VERMA S,BAUER R,et al.Deciphering strep tococcal biofilms[J].Microorganisms,2020,8(11):1835. [22] VYAS K S,WONG L K.Detection of biofilm in wounds as an early indicator for risk for tissue infection and wound chronicity[J].Ann Plast Surg,2016,76(1):127-131. [23] MASTERS E A,RICCIARDI B F,DE MESY BENTLEY K L,et al.Skeletal infections:microbial pathogenesis,immunity and clinical management[J].Nat Rev Microbiol,2022,20(7):385-400. [24] KOVÁCS R,MAJOROS L.Fungal quorum-sensing molecules:a review of their antifungal effect against Candida biofilms[J].JoF,2020,6(3):99. [25] EICK S.Biofilms[M]//Oral Biofilms.S.Karger AG,2020:1-11. [26] PEZZONI M,PIZARRO R A,COSTA C S.Role of quorum sensing in UVA-induced biofilm formation in Pseudomonas aeruginosa[J].Microbiology,2020,166(8):735-750. [27] DEL POZO J L.Biofilm-related disease[J].Expert Rev Anti Infect Ther,2018,16(1):51-65. [28] LIPSKY B A, BERENDT A R, CORNIA P B, et al.Executive summary: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections[J].Clin Infect Dis.2012, 54(12): 1679-1684. [29] SCOTLAND K B,LO J,GRGIC T,et al.Ureteral stent-associated infection and sepsis:pathogenesis and prevention:a review[J].Biofouling,2019,35(1):117-127. [30] HURLOW J,BLANZ E,GADDY J A.Clinical investigation of biofilm in non-healing wounds by high resolution microscopy techniques[J].J Wound Care,2016,25 Suppl 9(Sup9):S11-22. [31] MALONE M,SCHULTZ G.Challenges in the diagnosi s and management of wound infection[J].Br J Dermatol,2022,187(2):159-166. [32] RUPPITSCH W,STÖGER A,INDRA A,et al.Suitability of partial 16S ribosomal RNA gene sequence analysis for the identification of dangerous bacterial pathogens[J].J Appl Microbiol,2007,102(3):852-859. [33] NAKAGAMI G,SCHULTZ G,GIBSON D J,et al.Biofilm detection by wound blotting can predict slough development in pressure ulcers:a prospective observational study[J].Wound Rep And Reg,2017,25(1):131-138. [34] PARVIZI J,JACOVIDES C,ZMISTOWSKI B,et al.Definition of periprosthetic joint infection:is there a consensus?[J].Clin Orthop Relat Res,2011,469(11):3022-3030. [35] NEUT D,VAN HORN J R,VAN KOOTEN T G,et al.Detection of biomaterial-associated infections in orthopaedic joint implants[J].Clin Orthop Relat Res,2003,413:261-268. [36] LÉVY P Y,FENOLLAR F.The role of molecular diagnostics in implant-associated bone and joint infection[J].Clin Microbiol Infect,2012,18(12):1168-1175. [37] BAIDYA S,SHARMA S,MISHRA S K,et al.Biofilm formation by pathogens causing ventilator-associated pneumonia at intensive care units in a tertiary care hospital:an armor for refuge[J].Biomed Res Int,2021,2021:1-10. [38] BAIDYA S,SHARMA S,MISHRA S K,et al.Biofilm formation by pathogens causing ventilator-associated pneumonia at intensive care units in a tertiary care hospital:an armor for refuge[J].Biomed Res Int,2021,2021:8817700. [39] MERMEL L A,ALLON M,BOUZA E,et al.Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection:2009 Update by the Infectious Diseases Society of America[J].Clin Infect Dis,2009,49(1):1-45. [40] MUNSIFF S,LOUIE T.Prosthetic joint infections and rifampin[J].Clin Infect Dis,2022,75(4):739. [41] NISKA J A,SHAHBAZIAN J H,RAMOS R I,et al.Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice[J].Antimicrob Agents Chemother,2012,56(5):2590-2597. [42] MCCONEGHY K W,LAPLANTE K L.In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus[J].Diagn Microbiol Infect Dis,2010,68(1):1-6. [43] MAESTRE J R,AGUILAR L,MATEO M,et al.In vitro interference of tigecycline at subinhibitory concentrations on biofilm development by Enterococcus faecalis[J].J Antimicrob Chemother,2012,67(5):1155-1158. [44] SANTOS CARVALHAIS B E,DE SOUZA E SILVA C,DOS SANTOS K V.Effect of antimicrobials on Stenotrophomonas maltophilia biofilm[J].Future Microbiol,2021,16(2):83-93. [45] ROSSI D A,DUMONT C F,DE SOUZA SANTOS A C,et al.Antibiotic resistance in the alternative lifestyles of Campylobacter jejuni[J].Front Cell Infect Microbiol,2021,11:535757. [46] BASAS J,PALAU M,GOMIS X,et al.Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model[J].PLoS One,2019,14(2):e0212426. [47] BIRK S E,MAZZONI C,MOBASHARAH JAVED M,et al.Co-delivery of ciprofloxacin and colistin using microcontainers for bacterial biofilm treatment[J].Int J Pharm,2021,599:120420. [48] FORTES B N,SCHEUNEMANN G,DE AZEVEDO MELO A S,et al.Caspofungin alone or combined with polymyxin B are effective against mixed biofilm of Aspergillus fumigatus and carbapenem-resistant Pseudomonas aeruginosa[J].Res Microbiol,2023,174(1/2):103993. [49] GÓMEZ J,CANOVAS E,BAÑOS V,et al.Linezolid plus rifampin as a salvage therapy in prosthetic joint infections treated without removing the implant[J].Antimicrob Agents Chemother,2011,55(9):4308-4310. [50] FUJIMURA S,SATO T,HAYAKAWA S,et al.Antimicrobial efficacy of combined clarithromycin plus daptomycin against biofilms-formed methicillin-resistant Staphylococcus aureus on titanium medical devices[J].J Infect Chemother,2015,21(10):756-759. [51] JØRGENSEN N P,SKOVDAL S M,MEYER R L,et al.Rifampicin-containing combinations are superior to combinations of vancomycin,linezolid and daptomycin against Staphylococcus aureus biofilm infectionin vivoandin vitro[J].Pathog Dis,2016,74(4):ftw019. [52] BARBER K E,SMITH J R,IRELAND C E,et al.Evaluation of ceftaroline alone and in combination against biofilm-producing methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin and vancomycin in an in vitro pharmacokinetic/pharmacodynamic model[J].Antimicrob Agents Chemother,2015,59(8):4497-4503. [53] Comité Nacional de Neumonología; Comité Nacional de Nutrición; Comité Nacional de Gastroenterología,et al.[Guideline for the diagnosis and treatment of patients with cystic fibrosis. Update][J].Arch Argent Pediatr.2021, 119(1): s17-s35. [54] HANSEN C R,PRESSLER T,HØIBY N.Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients:15years experience[J].J Cyst Fibros,2008,7(6):523-530. [55] 杨新云,黎毅敏,魏理,等.大环内酯联用喹诺酮类药抑制铜绿假单胞菌生物被膜Meta分析[J].药物流行病学杂志,2011,20(6):288-290. [56] ÇIMŞIT M,UZUN G,YıLDıZ Ş.Hyperbaric oxygen therapy as an anti-infective agent[J].Expert Rev Anti Infect Ther,2009,7(8):1015-1026. [57] YU Q R,GRIFFIN E F,MOREAU-MARQUIS S,et al.In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells[J].J Antimicrob Chemother,2012,67(11):2673-2681. [58] SCHILCHER K,HORSWILL A R.Staphylococcal biofilm development:structure,regulation,and treatment strategies[J].Microbiol Mol Biol Rev,2020,84(3): e00026-19. [59] NAGOBA B S,SELKAR S P,WADHER B J,et al.Acetic acid treatment of pseudomonal wound infections-A review[J].J Infect Public Health,2013,6(6):410-415. [60] GOLD M H,ANDRIESSEN A,BHATIA A C,et al.Topical stabilized hypochlorous acid:the future gold standard for wound care and scar management in dermatologic and plastic surgery procedures[J].J Cosmet Dermatol,2020,19(2):270-277. [61] KATHRYN G.The effect of acidic maintenance solutions on catheter longevity[J].Nurs Times,2004,100(16):32-34. [62] GRUDZINSKI A,AGARWAL A,BHATNAGAR N,et al.Benefits and harms of citrate locking solutions for hemodialysis catheters:a systematic review and meta-analysis[J].Can J Kidney Health Dis,2015 , 2:13. [63] YOON B,JACKMAN J,VALLE-GONZÁLEZ E,et al.Antibacterial free fatty acids and monoglycerides:biological activities,experimental testing,and therapeutic applications[J].Int J Mol Sci,2018,19(4):1114. [64] DA SILVA R A G,AFONINA I,KLINE K A.Eradicating biofilm infections:an update on current and prospective approaches[J].Curr Opin Microbiol,2021,63:117-125. [65] KIM L.Persister cells:molecular mechanisms related to antibiotic tolerance[M]//COATES A.Antibiotic Resistance.Berlin,Heidelberg:Springer,2012:121-133. [66] SINGH K S,SHARMA R,REDDY P A N,et al.Retraction Note:IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance[J].Nature,2021,599(7885):518. [67] SANDOZ H.An overview of the prevention and management of wound infection[J].Nurs Stand,2022,37(10):75-82. [68] ALFEI S,CAVIGLIA D.Prevention and eradication of biofilm by dendrimers:a possibility still little explored[J].Pharmaceutics,2022,14(10):2016. [69] FLEMING D,RUMBAUGH K.Approaches to dispersing medical biofilms[J].Microorganisms,2017,5(2):15. [70] CHEUNG G Y C,BAE J S,LIU R,et al.Bacterial virulence plays a crucial role in MRSA sepsis[J].PLoS Pathog,2021,17(2):e1009369. [71] LIU Z Q,LIN Y Y,LU Q,et al.In vitro and in vivo activity of EDTA and antibacterial agents against the biofilm of mucoid Pseudomonas aeruginosa[J].Infection,2017,45(1):23-31. [72] BARRY D,MCGRATH P.Rotation disk process to assess the influence of metals and voltage on the growth of biofilm[J].Materials,2016,9(7):568. [73] RKEIN A M,OZOG D M.Photodynamic therapy[J].Dermatol Clin,2014,32(3):415-425. [74] WARRIER A,MAZUMDER N,PRABHU S,et al.Photodynamic therapy to control microbial biofilms[J].Photodiagnosis Photodyn Ther,2021,33:102090. [75] ZANWAR S,JAIN P,GOKARN A,et al.Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter-related bloodstream infection[J].Transpl Infect Dis,2019,21(1):e13017. [76] XU T Z,CHEN Z,CHEN Z F,et al.Development of the biomaterials technology for the infection resistance[J].Curr Pharm Des,2018,24(8):886-895. [77] JANSEN K U,GIRGENTI D Q,SCULLY I L,et al.Vaccine review:“Staphyloccocus aureus vaccines:problems and prospects”[J].Vaccine,2013,31(25):2723-2730. |
| [1] | 黄蓉, 张宁洁, 郝珂, 郭天虹, 黄雪原, 谷兰, 傅云峰, 黄远帅, 王勇军, 陈秉宇, 周岚, 桂嵘. 从《AABB技术手册》（18版-20版）看国际输血技术新走向*[J]. 临床输血与检验, 2023, 25(2): 170-179. |
| [2] | 治疗性单采过程管理与质量控制专家共识编写组. 治疗性单采过程管理与质量控制专家共识[J]. 临床输血与检验, 2023, 25(1): 1-9. |
| [3] | 李杨, 戎瑞明. 细胞治疗在肾脏移植中的应用前景*[J]. 临床输血与检验, 2022, 24(6): 687-692. |
| [4] | 陈蕊, 吕孟兴, 尹加忠, 沈经纬, 熊荣, 白云艳, 周文彪, 王旭, 杨琦, 屈柯暄. 云南省地中海贫血儿童输血安全策略的研究*[J]. 临床输血与检验, 2022, 24(6): 710-715. |
| [5] | 汪小钰, 刘丹, 张旭晗, 孙光宇, 陈二玲, 周紫微, 薛磊, 童娟, 周莉, 郑昌成. 不同剂量伊达比星联合阿糖胞苷对60岁以下成人急性髓系白血病诱导疗效的临床研究[J]. 临床输血与检验, 2022, 24(6): 791-797. |
| [6] | 杨颖, 路丽明, 李勤, 郭忠慧, 杨启修, 张嘉敏, 赵俸涌, 王晨, 朱自严. 肿瘤新抗原肽诱导献血者PBMC特异反应性T细胞*[J]. 临床输血与检验, 2022, 24(5): 565-573. |
| [7] | 张源秦, 徐璐, 马怡然, 杨融辉, 郝一文, 程大也, 丛桂敏. 毛细管离心术在胎母血型不一致的临床大量FMH综合征的诊断价值*[J]. 临床输血与检验, 2022, 24(5): 582-587. |
| [8] | 张浩, 方新梅, 张玛丽. 血糖控制达标的2型糖尿病视网膜病变患者外周血miR-3197、miR-2116-5p的表达水平及其临床价值*[J]. 临床输血与检验, 2022, 24(5): 635-642. |
| [9] | 吴军营, 王凌霞, 吴茜茜, 朱志宸, 王波, 杨欢. NFKBIZ基因在乳腺癌中的生物学功能及临床诊断价值研究*[J]. 临床输血与检验, 2022, 24(4): 482-487. |
| [10] | 刘静, 李龙, 马喜迎. γ-干扰素释放试验联合FadD9重组蛋白对重症肺结核患者的诊断及死亡预后的预测价值[J]. 临床输血与检验, 2022, 24(4): 488-496. |
| [11] | 肖洁, 杨俊龙, 高守曦, 宋辉, 朱晓艳, 丁汀. 换血成功治疗抗-Jra导致的胎儿新生儿溶血病1例并文献复习*[J]. 临床输血与检验, 2022, 24(4): 507-511. |
| [12] | 高宗帅, 李志强. 输血相关急性肺损伤诊断国际专家共识再认识*[J]. 临床输血与检验, 2022, 24(4): 528-532. |
| [13] | 肖勇, 贺海东, 胡屏, 孙蔚倩, 徐旭东, 唐余燕. IgA肾病患者肠黏膜屏障功能与血清Gd-IgA1相关性研究*[J]. 临床输血与检验, 2022, 24(3): 357-362. |
| [14] | 王倩, 杨李辉, 丁天凌, 夏荣. 自体造血干细胞移植中不同预处理方案与血小板输注的临床分析*[J]. 临床输血与检验, 2021, 23(6): 686-692. |
| [15] | 沈国栋, 栾建凤. 疑难血型肝衰竭患者紧急肝移植与输血策略——附1例报道[J]. 临床输血与检验, 2021, 23(6): 693-695. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
